Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany; Department of Gastroenterology and Hepatology, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Department of Surgery, Campus Virchow-Klinikum and Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Surg Oncol. 2020 Jun;33:257-265. doi: 10.1016/j.suronc.2020.02.004. Epub 2020 Feb 8.
Advances in anaesthesia and surgical technique have considerably reduced mortality in hepatocellular carcinoma (HCC) patients undergoing liver resection. However, extended resections in patients with liver cirrhosis still represent a challenge. The aim of this study was to investigate the predictive value of volume/function analysis for the prediction of morbidity in HCC patients following liver resection.
Between 2001 and 2014, a total of 261 patients who underwent open hepatectomy for HCC were enrolled in this study. Future liver remnant volume (FLRV) and future liver remnant function (FLRF) based on LiMAx testing were obtained retrospectively. Uni- and multivariable analyses were performed to identify predictors for postoperative ascites, post-hepatectomy haemorrhage (PHH), and wound healing disorders (WHD) within the total cohort and in a subgroup of cirrhotic patients.
The most commonly observed complication was ascites (57.1%), followed by liver failure (25.3%), PHH (19.5%), and WHD (19.2%). FLRF was a major predictor of postoperative ascites (AUC 0.776; OR 0.987, p = 0.001), PHH (AUC 0.717; OR 0.984, p = 0.001), and WHD (AUC 0.660; OR 0.994, p = 0.032) in total cohort. Multivariable analysis of the cirrhosis subgroup showed FLRF to be an independent predictor of ascites (AUC 0.814; OR 0.989, p = 0.021), PHH (AUC 0.677; OR 0.991, p = 0.040), and WHD (AUC 0.615; OR 0.989, p = 0.033).
FLRF is a major predictor of postoperative ascites, haemorrhage, and wound healing disorders in cirrhotic and non-cirrhotic patients whereas FLRV failed to show significant correlations. Preoperative calculation of FLRF may augment surgical decision-making in high-risk patients and thereby improve perioperative outcome.
麻醉和外科技术的进步显著降低了接受肝切除术的肝细胞癌(HCC)患者的死亡率。然而,在肝硬化患者中进行广泛切除术仍然是一个挑战。本研究旨在探讨体积/功能分析对预测 HCC 患者肝切除术后发病率的价值。
2001 年至 2014 年间,共纳入 261 例接受开腹肝切除术的 HCC 患者。回顾性获得基于 LiMAx 检测的剩余肝体积(FLRV)和剩余肝功能(FLRF)。在总队列和肝硬化患者亚组中进行单变量和多变量分析,以确定术后腹水、肝切除术后出血(PHH)和伤口愈合障碍(WHD)的预测因素。
最常见的并发症是腹水(57.1%),其次是肝功能衰竭(25.3%)、PHH(19.5%)和 WHD(19.2%)。FLRF 是术后腹水(AUC 0.776;OR 0.987,p=0.001)、PHH(AUC 0.717;OR 0.984,p=0.001)和 WHD(AUC 0.660;OR 0.994,p=0.032)的主要预测因素。肝硬化亚组的多变量分析显示,FLRF 是腹水(AUC 0.814;OR 0.989,p=0.021)、PHH(AUC 0.677;OR 0.991,p=0.040)和 WHD(AUC 0.615;OR 0.989,p=0.033)的独立预测因素。
FLRF 是肝硬化和非肝硬化患者术后腹水、出血和伤口愈合障碍的主要预测因素,而 FLRV 则没有显示出显著的相关性。术前计算 FLRF 可能会增加高危患者的手术决策能力,从而改善围手术期结果。